Institutional Fund
Broadwood Capital Inc
New York, NYCIK 12783875 filings on record
Portfolio Value
$1.42B
Q1 2026
Holdings
6
Reported positions
New Buys
0
Opened this quarter
QoQ Change
-14.3%
from $1.65B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Monster Beverage Corp New41.4%
- Staar Surgical Co21.3%
- Axon Enterprise Inc20.8%
- Ishares Tr8.3%
- Lineage Cell Therapeutics In5.5%
- Insight Molecular Dia Inc2.8%
Portfolio Holdings
6 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Monster Beverage Corp New | 8.11M | $587.49M | 41.4% | −91.2K | Reduced |
| 2 | Staar Surgical Co | 16.12M | $301.52M | 21.3% | +1.10M | Added |
| 3 | Axon Enterprise Inc | 693.5K | $294.52M | 20.8% | 0 | Held |
| 4 | Ishares Tr | 474.9K | $117.78M | 8.3% | 0 | Held |
| 5 | Lineage Cell Therapeutics In | 49.56M | $78.31M | 5.5% | 0 | Held |
| 6 | Insight Molecular Dia Inc | 11.93M | $39.14M | 2.8% | +521.7K | Added |